Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Abhishek Kapoor Article rating: 3.5

The market opened in the green on June 16, 2020, overall volumes in futures & options currently stand at 2.12 crore contracts with a turnover of Rs. 12,02,860.24 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Abhishek Kapoor Article rating: 3.7

The market opened in the green on June 16, 2020, overall volumes in futures & options currently stand at 2.12 crore contracts with a turnover of Rs. 12,02,860.24 crore.

Mutual Fund investors turn cautious now!
Mutual Fund investors turn cautious now!

Mutual Fund investors turn cautious now!

Shashikant Singh Article rating: 4.5

The month of May 2020 saw 46-month low gross inflows into equity mutual fund (MF) schemes. The investor seems to be cautious now on their MF investment.

Cadila gets final USFDA approval to market Deferasirox tablets
Cadila gets final USFDA approval to market Deferasirox tablets

Cadila gets final USFDA approval to market Deferasirox tablets

Nidhi Jani Article rating: 4.1

The company has received USFDA nod to market Deferasirox tablets (90 mg, 180 mg and 360 mg), which is used for treating high levels of iron in patients, having a certain blood disorder.

COVID-19 affects May exports adversely; exports plunge 36 per cent
COVID-19 affects May exports adversely; exports plunge 36 per cent

COVID-19 affects May exports adversely; exports plunge 36 per cent

Nidhi Jani Article rating: 5.0

However, the drop in exports during the month under review is low as compared to 60.28 per cent fall in April 2020. Trade deficit, gap between imports and exports, narrowed to US$ 3.15 billion in May 2020 from US$ 15.36 billion a year ago.

Alembic Pharmaceutical touches 52-week high, gets fresh USFDA approval
Alembic Pharmaceutical touches 52-week high, gets fresh USFDA approval

Alembic Pharmaceutical touches 52-week high, gets fresh USFDA approval

Pratik Shastri Article rating: 5.0

The IQVIA, a US-based company, which is engaged in serving as the information and database provider of the healthcare industry, stated that Deferasirox Tablets, 180 mg, has an estimated market size of US$ 53 million (Rs 400 crore approximately).

GlobalSpace Technologies gains popularity in STEAM education space
GlobalSpace Technologies gains popularity in STEAM education space

GlobalSpace Technologies gains popularity in STEAM education space

Chinmayee D Article rating: 3.9

The EduTech subsidiary, Makebot Robotic Solutions Pvt Ltd of GlobalSpace is surfacing as a leader in STEAM education using robotics, artificial intelligence (AI), internet of things (IOT) platforms for all the students across K-12.

Ind-Swift Lab gets ready to launch new API in US markets
Ind-Swift Lab gets ready to launch new API in US markets

Ind-Swift Lab gets ready to launch new API in US markets

Nidhi Jani Article rating: 3.3

Speaking only of US, the revenue contribution stands at approximately 14 per cent and the company delivers seven to eight products to the US markets. This new API launch would be a different opportunity for the company as US is a significant market for Fexofenadine.

Gap-up opening for markets!
Gap-up opening for markets!

Gap-up opening for markets!

Karan Dsij Article rating: 5.0

The announcement from US Fed to purchase individual corporate debt is likely to boost the sentiment on the Dalal Street. Early trends on SGX Nifty suggests that bulls are likely to hit a double century at the opening bell. At 7:51 am, SGX Nifty was trading up by 1.97 per cent at 9,889.50 levels.

RSS
First21122113211421152117211921202121Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR